Plasmid Info:
Plasmid Information
Product Name: pSF-CMV-Puro-COOH-Thr-Strep
Product Code: OG1092
Size (bp): 6192 bp
Bacterial Antibiotic Selection: KanR
Origin and Compatibility: pUC high copy derived from pBR322
Bacterial Copy Number: 500-700 per cell
Promoter: Cytomegalovirus (CMV) immediate early promoter / Human Ubiquitin Promoter
Plasmid Purpose:
This plasmid is designed to express tagged proteins in mammalian cells either by transient transfection or by creating stable cell lines. It contains a puromycin resistance expression cassette using the human Ubiquitin promoter to drive expression and allow for the selection of cells containing the plasmid.
About the Cleavage Tag:This plasmid also encodes a protease cleavage site that is designed to be positioned between your gene of interest and the tag to allow the removal of the tag following protein purification or isolation. This plasmid contains a Thrombin cleavage tag. The protein sequence of the cleavage tag is: LVPR?GS. It cleaves preferentially between the Arg and Gly residues. Off target cleavage can often occur at non-specific sites normally from other contaminating proteases. To ensure maximal protein integrity the enzyme reagent must be highly pure.
For more information on which cleavage tag to use see our cleavage tag guide.
Promoter Expression Level:This plasmid contains the mammalian CMV promoter to drive gene expression. We have tested all of our mammalian promoters in a range of cell types and CMV is consistently the strongest in those we have studied. However there are many reports of the CMV promoter demonstrating silencing by methylation in long-term culture. For this reason we stock a range of other promoters that are compatible with this plasmid and are available on request.

This plasmid contains a c-terminal Strep affinity tag that can be fused to a gene of interest to allow protein detection and/or purification. The sequence of the tag is: WSHPQFEK
For more information on the methods that can be used to purify proteins please see our protein tag guide.
Sequence and Map:
Other Info:
Transcription Termination:This plasmid contains three alternative transcription terminators for mammalian bacterial and bacteriophage (T7) expression. This means that only the promoter needs to be changed to alter the expression system you are using. We sell multiple promoters that can be used in each of these systems. The presence of each terminator does not reduce expression in the alternative systems.
Cloning:
Making Protein Fusions:This plasmid has been designed to allow three types of cloning into the main MCS to join a coding sequence with the tag.
SnapFusion Cloning:If you would like to fuse your coding sequence to the tag with minimal additional bases you can use our SnapFusion technology. This process involves amplifying your gene by PCR to add specific restriction sites onto the ends. When these sites are cut they produce an overhang that is compatible with this plasmid cut with BseRI or BsgI.
To insert your gene:
1: Amplify your gene with primers designed using this spreadsheet
2: Cut the plasmid with either BseRI or BsgI.*
3: Cut your gene with the enzyme you added using the spreadsheet (any of AcuI BpmI BpuEI BseRI BsgI EciI).
4: Clone the gene into the plasmid using DNA ligase.
Using this method with an N-terminal tag plasmid will result in the tag coding sequence immediately followed by your genes ATG start codon at the join. This results in a seamless fusion of the two sequences with no extra bases being added. Using this method on C-terminal tag plasmids will convert your genes stop codon into a TAC (Tyr Y) codon followed by the plasmid tag coding sequence. This results in no extra bases between your gene and the tag. See the diagram below for more information.
*Please note that insect expression plasmids cannot be cut with BsgI only BseRI because of unavoidable conflicting sites in the backbone. Also Yeast plasmids can only be cut with BsgI not BseRI because of conflicting sites in the backbone.
Using this technique will create a gene fragment that can be ligated into any or our >1500 peptide and reporter tag plasmids. If you use one of the other techniques below (Gibson InFusion Seamless or LIC) you will need new primers for every vector you clone into because the arms of homology will change according to the tag plasmid you are cloning into.
If you find that your gene sequence has sites in it that make using this cloning strategy difficult you can still use one of the alternative methods below (e.g. standard cloning or Gibson cloning).
Open the Primer Design Tool to help you design primers for cloning your gene in our SnapFusion technique.
Standard Enzymes:If you are not concerned about leaving a few extra bases between the tag coding sequence and your gene you can clone your gene into the vector using standard cloning restriction enzymes. This strategy will require you to choose which enzymes you want to use to clone your gene.
Open the Primer Design Tool which provides primers with different enzyme choices positioning your gene as close to the tag as possible in each case. Please note that standard enzymes will always leave additional nucleotides between your gene and the tag but using the spreadsheet will ensure the tag and gene are in frame.
Gibson cloning/InfusionHD/GeneArt Seamless/Ligase Independent Cloning (LIC) Methods:
These cloning techniques use reagents sold by other companies and allow you to fuse sequences together using enzymes that chew back the DNA to leave overlapping ends/overhangs. The subsequent method of joining the DNA depends on the kit used. To use one of these techniques you can either design your own primers or you can use the spreadsheet below to help with the design.
Open the Primer Design Tool to help you design primers for cloning your gene using Gibson assembly InfusionHD GeneArt Seamless cloning or Ligase Independent Cloning (LIC) techniques.

IP Status:
Intellectual Property StatusThis product is part of our SnapFast plasmid range, for more information on the Intellectual property status of this plasmid please click here
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
完整的表达载体必须包括:
1、复制子,在细菌中扩增时所必须.
2、启动子,目的基因在细菌或细胞中转录所必须,转录了才能翻译,是谓“表达”.
3、原核筛选标记,细菌增菌所必须.
4、真核筛选标记,如果是真核表达,就是必须的.
5、多克隆位点,即酶切位点,插入目的片段的区域.
6、其他所需构件,可视实验设计情况而选用现成载体或在载体上自行添加.
另:表达的起始和终止,在目的基因上附带起始密码子和终止密码子.
1. 宿主范围广, 对人致病性低
腺病毒载体系统可广泛用于人类及非人类蛋白的表达。腺病毒可感染一系列哺乳动物细胞,因此在大多哺乳动物细胞和组织中均可用来表达重组蛋白。特别需要指出的是:腺病毒具有嗜上皮细胞性,而人类的大多数的肿瘤就是上皮细胞来源的。另外,腺病毒的复制基因和致病基因均已相当清楚,在人群中早已流行(70-80%成人体内都有腺病毒的中和抗体存在)。人类感染野生型腺病毒后仅产生轻微的自限性症状,且病毒唑治疗有效。
2.
在增殖和非增殖细胞中感染和表达基因
逆转录病毒只能感染增殖性细胞,因此DNA转染不能在非增殖细胞中进行,而必须使细胞处于持续培养状态。腺病毒则能感染几乎所有的细胞类型,除了一些抗腺病毒感染的淋巴瘤细胞。腺病毒是研究原代非增殖细胞基因表达的最佳系统,它可以使转化细胞和原代细胞中得到的结果直接进行对比。
3.
能有效进行增殖,滴度高
腺病毒系统可产生1010到1011VP/ml,浓缩后可达1013VP/ml,这一特点使它非常适用于基因治疗。
4.
与人类基因同源
腺病毒载体系统一般应用人类病毒作为载体,以人类细胞作为宿主,因此为人类蛋白进行准确的翻译后加工和适当的折叠提供了一个理想的环境。大多数人类蛋白都可达到高水平表达并且具有完全的功能。
5.
不整合到染色体中,无插入致突变性
逆转录病毒可随机整合到宿主染色体,导致基因失活或激活癌基因。而腺病毒则除了卵细胞以外几乎在所有已知细胞中都不整合到染色体中,因此不会干扰其它的宿主基因。在卵细胞中整合单拷贝病毒则是产生具有特定特征的转基因动物的一个较好的系统。
6.
能在悬浮培养液中扩增
293细胞可以适应悬浮培养,这一调整可使病毒大量扩增。大量事实证明悬浮293细胞可在1~20L的生物反应器中表达重组蛋白。
7. 能同时表达多个基因
这是第一个可以在同一细胞株或组织中用来设计表达多个基因的表达系统。最简单的方法是将含有两个基因的双表达盒插入腺病毒转移载体中,或者用不同的重组病毒共转染目的细胞株来分别表达一个蛋白。测定不同重组病毒的MOI比值可正确估计各重组蛋白的相对共表达情况。
正是由于具有以上一些优点,腺病毒被极其广泛地应用于体外基因转导、体内接种疫苗、和基因治疗等各个领域。
启动子是RNA聚合酶能够识别并与之结合,从而起始基因转录的一段DNA序列,通常位于基因上游.一个典型的启 动子包括CAAT-box和TATA-box,它们分别依赖DNA的RNA聚合酶的识别和结合位点,一般位于转录起始位点上游几十个碱基处.在核心启动子上 游通常会有一些特殊的DNA序列,即顺式作用元件,转录因子与之结合从而激活或抑制基因的转录.一旦RNA聚合酶定位并结合在启动子上即可 启动基因转录,因此启动子是基因表达调控的重要元件,它与RNA聚合酶及其他蛋白辅助因子等反式作用因子的相互作用是启动子调控基因转录的实质.
根据启动子的转录模式可将其分为3类:组成型启动子、组织或器官特异性启动子和诱导型启动子.
这是从clontech拿到的载体。 看着和慢病毒差不多但是说明上写要用他公司的Lenti-X™ HT Packaging System来包装。 那这个意思是买完这个载体还要去买他的包装系统?这个也太麻烦了吧
常用细菌质粒进行构建,构建过程中运用限制性核酸内切酶切割出与目的基因相合的末端(多为黏性末端,也有平末端),采用DNA连接酶连接,导入生物体实现表达。标记基因可帮助识别质粒并检测是否成功整合到染色体DNA中。
表达载体(Expression vectors)就是在克隆载体基本骨架的基础上增加表达元件(如启动子、RBS、终止子等),使目的基因能够表达的载体。如表达载体pKK223-3是一个具有典型表达结构的大肠杆菌表达载体。其基本骨架为来自pBR322和pUC的质粒复制起点和氨苄青霉素抗性基因。在表达元件中,有一个杂合tac强启动子和终止子,在启动子下游有RBS位点(如果利用这个位点,要求与ATG之间间隔5-13bp),其后的多克隆位点可装载要表达的目标基因。
早期基因捕获载体的特点是当报告基因与内源基因的读码框一致时,产生由内源蛋白的N 末端与报告基因蛋白融合的活性蛋白质 。近来对这一类载体所做的改进是在报告基因与SA 序列间插入一来源于脑、心肌炎病毒的IRES ,这样即使报告基因与捕获基因不发生融合也可产生报告基因翻译产物。尽管ES 细胞中大量基因具转录活性,为了获得全基因组突变克隆必须使用不依赖于捕获基因表达的筛选策略。

![]()
暂无品牌分类
